Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)

View source ↗

Summary

A completed clinical trial evaluating adverse events and changes in disease state in adults with Pyoderma Gangrenosum treated with Humira (adalimumab).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Pyoderma Gangrenosum | Status: COMPLETED